Market Newsdesk

MARIETTA, Ga., Nov. 12, 2020 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, MiMedx Chief Executive Officer, and Peter M. Carlson, MiMedx Chief Financial Officer, will present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020, beginning at 9:30 am, Eastern Time.

A live webcast of the presentation will be available on the Events page of the Investors section of the Company’s website or through the conference site by using the link below.

Date: Thursday, November 19, 2020
Time: 9:30 AM ET
Webcast: https://wsw.com/webcast/canaccord44/mdxg/2454624 

A replay of the webcast will be available for approximately 45 days on the Company’s website at www.mimedx.com following the conclusion of the presentation.

About MiMedx

MiMedx^® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION^® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied more than two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.

Contact

Hilary Dixon
Investor Relations & Corporate Communications
770.651.9066
[email protected]

 

‘S-HERTOGENBOSCH, the Netherlands, Nov. 12, 2020 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy management technology company and the world’s leading supplier of microinverter-based solar-plus-storage systems, today announced a strategic partnership with DMEGC Solar Energy, a vertically integrated manufacturer of solar photovoltaic (PV) products from poly silicon to modules, to develop high-efficiency Enphase Energized™ AC modules (ACM) for the European residential solar market. These ACMs are currently available in France and the Netherlands.

The Mono PERC Black Enphase Energized ACM in Europe features Enphase IQ 7™ and IQ 7+™ microinverters. Incorporating advanced mono PERC half-cut cell technology, the DMEGC Black ACM produces outstanding yields due to power classes of up to 340 Wp and efficiencies of up to 20.15%. The ACM also offers best-in-class quality manufacturing according to international quality standards and 100% EL testing performed twice during production. The Mono PERC DMEGC ACM enables installers to be more competitive through improved capital management, reduced labor costs, improved SKU management with accelerated design, and faster installation times. 

“We see a promising future for our partnership with Enphase Energy in European countries, particular in countries like France and the Netherlands, where quality, innovation and aesthetics are key for residential PV solutions,” said Erik Das, sales director at DMEGC Solar Europe. “Enphase Energized AC modules offer remote monitoring, rapid shutdown, quality design, and simple installation. Their lower maintenance costs and high safety features are much appreciated in our competitive solar markets.”

The seventh-generation Enphase IQ™ microinverter system leverages Enphase’s unique software-defined architecture and semiconductor integration for excellent reliability and economies of scale. Enphase microinverters are subjected to a rigorous reliability and quality testing regimen with more than an aggregated one million hours of cumulative power-on testing to ensure exceptional performance under heat, high humidity, salty air, and extreme cold. The Company’s microinverters are designed to be long-lived energy assets and are backed by a 25-year limited warranty.

“Our experience with installing the DMEGC ACM has been very positive, as we have benefitted from the product’s fewer components and ease of installation,” said Janneke vd. Kerkhoff, owner at Goforsunpower, the Netherlands. “We are pleased to know the ACM is powered by Enphase microinverters, which are designed to be safe, reliable and future-proof.”

Enphase Energized AC modules from DMEGC Solar Energy work seamlessly with Enphase IQ accessory products: the lighter two-wire Enphase Q Cable™, Enphase Envoy-S™ gateway and Enphase Envoy-S metered gateway with split core current transformers (CTs) for production and consumption monitoring. Solar installers who select the Mono PERC ACM can monitor their solar fleets remotely using the powerful cloud-based Enphase Enlighten™ monitoring system, and rely on the Enphase support team to deliver an outstanding customer experience.

“Our partnership with DMEGC Solar Energy is another validation of the high-efficiency AC module concept and Enphase microinverter technology for the European solar market,” said Dave Ranhoff, chief commercial officer at Enphase Energy. “We are pleased to join forces with such a high-quality AC module manufacturer in Europe, where Enphase microinverters continue to have broad appeal for both solar installers and homeowners.”

For more information about the Enphase Energized AC Modules from DMEGC, visit the Enphase Energy website.

About Enphase Energy, Inc.

Enphase Energy, a global energy technology company, delivers smart, easy-to-use solutions that connect solar generation, storage and management on one intelligent platform. The Company revolutionized solar with its microinverter technology and produces the world’s only truly integrated solar plus storage solution. Enphase has shipped more than 30 million microinverters, and approximately 1.3 million Enphase-based systems have been deployed in more than130 countries. For more information, visit www.enphase.com/de and follow the company on Facebook, LinkedIn and Twitter.

Enphase Energy®, the Enphase logo, Enphase Energized, IQ, IQ 7+, Q Cable, Envoy-S, Enlighten, and other trademarks or service names are the trademarks of Enphase Energy, Inc. Other names are for informational purposes and may be trademarks of their respective owners.

Forward-Looking Statements


This press release may contain forward-looking statements, including statements related to the expected performance and advantages of Enphase Energy’s technology and products, including quality, safety, reliability, lower costs, the ease of installation and being “future-proof”; the capabilities of its customer service teams; anticipated product adoption; and the capabilities and performance of its partners’ products and services. These forward-looking statements are based on Enphase’s current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of certain risks and uncertainties including those risks described in more detail in Enphase’s most recent Annual Report on Form 10-K and other documents on file with the SEC and available on the SEC’s website at www.sec.gov. Enphase Energy undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations, except as required by law.

Enphase
Energy
Contact:

Robert Gruijters
Marketing Director, EMEA
[email protected]
Telephone: +31-6-82390633 

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Credit Acceptance Corporation (“Credit Acceptance” or the “Company”) (NASDAQ: CACC).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether Credit and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On August 13, 2020, Credit Acceptance disclosed that on August 11, 2020, the Company had received subpoenas from the Attorney General of the State of Maryland and from the Attorney General of the State of New Jersey.  Describing the subpoenas as “substantively identical” to one another, Credit Acceptance advised investors that the subpoenas both “relat[ed] to the Company’s repossession and sale policies and procedures” and “the Company’s origination and collection policies and procedures.”  Taken together with previously disclosed subpoenas received in March 2016 and April 2020, Credit Acceptance advised investors that the inquiries it faced now related to its operations in 39 states. 

On this news, Credit Acceptance’s stock price fell $19.05 per share, or 3.84%, over the following two trading sessions, closing at $476.78 per share on August 17, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980

VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) — Sabina Gold & Silver Corp (SBB.T/SGSVF.OTCQX), (“Sabina” or the “Company”) is pleased to report that the detail engineering contract has been awarded and work has commenced on the Goose Mine at its 100%-owned Back River Gold Project (“Back River” or the “Project”) in Nunavut, Canada.

After comprehensive evaluation of various construction delivery methods for the Process Plant at Goose, Sabina believes that a modified Engineering, Procurement, Construction Management (“EPCM”) method offers the greatest efficiency, flexibility and risk mitigation for development of the Goose Project.

This delivery model includes completion of detail engineering in a reimbursable cost model for engineering and procurement directly sourcing major process equipment, and pursuit of a fixed price construction bid.

Detail engineering will provide definitive material requirements per AACE class II standards (up to 70% project definition) and will result in development of procurement packages and delivery of issued for construction drawings. This approach de-risks the engineering aspect, better defines the execution plan and provides greater certainty of procurement and construction costs. With these details in hand, Sabina will solicit fixed price construction bids for the plant, including performance guarantees.

CONSULTANTS

Sabina has engaged Sacré-Davey Engineering Inc. (“SD”) to complete the detail engineering scope for the process plant and experienced Arctic builders, CGT Industrial (“CGT”) to review and evaluate the detailed design’s constructability and operability. The CGT team is also assisting in developing a construction execution plan.

SD has extensive experience ranging from feasibility studies and concepts to detailed design, system integration, and construction. They have executed projects across many industries, including mining, oil & gas, and forestry, among others.

CGT is a northern Arctic constructor with proven experience in the mining industry with a successful track record of involvement in projects that includes Pretivm’s Brucejack gold mine, Dominion Diamond’s Ekati and Diavik Diamond mines and Yukon Zinc’s Wolverine mine.

Both detailed engineering and the constructability and operations review have begun and are expected to be completed during Q1, 2021.

“We are pleased to be working with Sacre Davey and CGT on these initiatives,” said Bruce McLeod, President & CEO. “Both firms have significant experience which we believe aligns with Sabina’s approach to this Project. We also believe that given the global supply chain volatility due to the COVID-19 pandemic, this revised delivery approach bodes well for delivering more certainty around project costs and deliverables. We look forward to reporting further on our pre-development activities as they progress.”

OTHER KEY INITIATIVES

Sabina had selected FLSmidth (“FLS”) as the equipment manufacturer and FLS is actively working on their line-up of equipment and a definitive pricing model with a performance guarantee for the plant. FLS will also be engaged in commissioning support and critical spares management. This continued engagement with FLS will provide Sabina with more certainty for the phases of the Project throughout detailed engineering, commissioning, optimization, and training.

Sabina is also reaching out to power plant technology providers to support the design and development of construction drawings for a ~15MW power plant. Sabina expects this contract will be awarded before the end of the year.  

Sabina has engaged DT Engineering to design the Port Facility fuel farm and fuel distribution process. The objective is to receive, store and dispense 40 Million liters at the Port Facility area and at the Goose site.

Sabina consultants are also working on the design of various water diversion structures designed to mitigate seasonal flow, site wide road networks, waste dump designs and site wide water balance calculations.

In 2019 Sabina obtained a third-party logistics review for Project construction.  As part of the process, Sabina engaged various vessel operators to do a logistics review while finalizing plans for the material consolidation points for the Project, the Port Facility receiving schedule and offloading requirements. The inaugural winter ice road in 2018/19 provided the experience required to develop a robust logistics and procurement execution plan to support the Project’s material requirements.  The opportunity enabled Sabina to conduct winter ice road time studies and road management plans.  All these initiatives have been carried forward and will be incorporated into the updated Project execution plan. 

Sabina Gold & Silver Corp.

Sabina Gold & Silver Corp. is well-financed and is an emerging precious metals company with district scale, advanced, high grade gold assets in one of the world’s newest, politically stable mining jurisdictions: Nunavut, Canada.

Sabina released a Feasibility Study on its 100% owned Back River Gold Project which presents a project that has been designed on a fit-for purpose basis, with the potential to produce ~200,000 ounces a year for ~11 years with a rapid payback of 2.9 years (see “Technical Report for the Initial Project Feasibility Study on the Back River Gold Property, Nunavut, Canada” dated October 28, 2015).

The Project received its final Project Certificate on December 19, 2017. The Project received its Type A Water License on November 14, 2018 and its listing to enable deposition of tailings on Schedule 2 of the Metals and Diamond Mining Effluent Regulations on June 25, 2020. The Company is now in receipt of all major authorizations for construction and operations.

In addition to Back River, Sabina also owns a significant silver royalty on Glencore’s Hackett River Project. The silver royalty on Hackett River’s silver production is comprised of 22.5% of the first 190 million ounces produced and 12.5% of all silver produced thereafter.

For further information please contact:

Nicole Hoeller, Vice-President, Communications: 1 888 648-4218
[email protected]

Forward Looking Information

This news release contains “forward-looking information” within the meaning of applicable securities laws (the “forward-looking statements”), including our belief as to the extent, results and timing of and various studies relating to engineering studies, infrastructure improvement activities, exploration results and permitting and licensing outcomes. These forward-looking statements are made as of the date of this news release. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the future circumstances, outcomes or results anticipated in or implied by such forward-looking statements will occur or that plans, intentions or expectations upon which the forward-looking statements are based will occur. While we have based these forward-looking statements on our expectations about future events as at the date that such statements were prepared, the statements are not a guarantee that such future events will occur and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Such factors and assumptions include, among others, the effects of general economic conditions, commodity prices, changing foreign exchange rates and actions by government and regulatory authorities and misjudgments in the course of preparing forward-looking statements. In addition, there are known and unknown risk factors which could cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Known risk factors include risks associated with exploration and project development; the need for additional financing; the calculation of mineral resources and reserves; operational risks associated with mining and mineral processing; fluctuations in metal prices; title matters; government regulation; obtaining and renewing necessary licenses and permits; environmental liability and insurance; reliance on key personnel; the potential for conflicts of interest among certain of our officers or directors; the absence of dividends; currency fluctuations; labour disputes; competition; dilution; the volatility of the our common share price and volume; future sales of shares by existing shareholders; and other risks and uncertainties, including those relating to the Back River Project and general risks associated with the mineral exploration and development industry described in our Annual Information Form, financial statements and MD&A for the fiscal period ended December 31, 2019 filed with the Canadian Securities Administrators and available at www.sedar.com. Although we have attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. We are under no obligation to update or alter any forward-looking statements except as required under applicable securities laws. This news release has been authorized by the undersigned on behalf of Sabina Gold & Silver Corp.

Bruce McLeod, President & CEO
Suite 1800 – Two Bentall Centre
555 Burrard Street
Vancouver, BC V7X 1M7
Tel 604 998-4175 Fax 604 998-1051
http://www.sabinagoldsilver.com

Fulton, MD and Frederick, MD, Nov. 12, 2020 (GLOBE NEWSWIRE) — Sonatype, the leading provider of innovation-friendly open source security tools, today announced a strategic partnership with Fugue, the company putting engineers in command of cloud security, to deliver the first infrastructure-as-code (IaC) solution that shifts cloud security left into the developer workflow. The partnership further advances the missions of Sonatype and Fugue to empower software developers with best-in-class tools so they can accelerate innovation and simultaneously improve application security, cloud infrastructure security, and continuous compliance with defined policy.

The combined capabilities of Sonatype and Fugue enable developers to find and fix security vulnerabilities when actively developing cloud applications, while at the same time preventing security vulnerabilities and compliance issues from surfacing in production due to misconfigured cloud infrastructure. The joint solution includes out-of-the-box guidance to assist developers when configuring IaC and automatically foster compliance with privacy and security standards, including CIS Foundations Benchmarks, GDPR, HIPAA, ISO 27001, NIST 800-53, PCI, SOC 2, and custom rules.   

“Sonatype has a long and successful history of providing front-line software developers with friendly feedback pertaining to the health of open source libraries, making it easy for them to identify and remediate security risk, without slowing down innovation,” said Wayne Jackson, CEO of Sonatype. “In today’s cloud-native world, developers are not just responsible for building secure applications, they’re also responsible for configuring and provisioning secure cloud infrastructure using tools like Terraform. By working with Fugue, we’re equipping developers with the right information at the right time so they can always make healthy decisions when configuring IaC.”

In Q1 2021, Sonatype will offer new Nexus IaC capabilities as an add-on to its Nexus Lifecycle product that incorporates Fugue’s cloud infrastructure security and compliance technology. This will make it possible for developers using Nexus Lifecycle to find and easily fix misconfigurations in Terraform plans before being applied to production infrastructure, and use those same policies with Fugue to ensure continuous compliance in production.  

For initial details, and to sign up to learn more about Sonatype’s Nexus Lifecycle IaC capabilities, go here. Additionally, Sonatype and Fugue will collaborate to bring the Fugue runtime SaaS continuous compliance solution to Sonatype customers, who can learn more here.

“Sonatype and Fugue have a strong history of leadership in empowering developers to securely build and operate in order to keep their data safe. We’re proud to partner with them to deliver a single solution to address the full breadth of cloud security and compliance challenges,” said Phillip Merrick, CEO of Fugue. “The mutable nature of cloud APIs brings serious risk of post-deployment misconfiguration, and Sonatype and Fugue are making it possible for the first time to address all relevant cloud vulnerability surfaces — from initial development to runtime production environments — with a single solution using the same policies.”  

Full Breadth Cloud Security and Compliance

Sonatype and Fugue are delivering a unified cloud security and compliance solution that empowers software developers to address the entire cloud threat landscape with:

• Open-source governance with Sonatype’s Nexus platform to shift security of software applications left to address open source risk and known vulnerabilities automatically at every phase of the CI/CD pipeline.
• Infrastructure-as-code governance with Sonatype’s new IaC capabilities, which integrate Fugue’s cloud infrastructure security and compliance technology for Terraform configurations.
• Continuous cloud compliance with Fugue to ensure cloud environments remain in compliance and free of misconfiguration vulnerabilities post-deployment — and demonstrate it at all times with automated reporting. 

About Sonatype 

Sonatype is the leader in software supply chain automation technology with more than 350 employees, over 1,200 enterprise customers, and is trusted by more than 10 million software developers.  Sonatype’s Nexus platform enables DevOps teams and developers to automatically integrate security at every stage of the modern development pipeline by combining in-depth component intelligence with real-time remediation guidance. For more information, please visit Sonatype.com, or connect with us on Facebook, Twitter, or LinkedIn.

About Fugue

Fugue puts engineers in command of enterprise cloud security with tools to prove compliance, build security into cloud development, and stay safe by eliminating cloud misconfiguration. Fugue provides one-click reporting for CIS Foundations Benchmarks, GDPR, HIPAA, ISO 27001, NIST 800-53, PCI, and SOC 2. Customers such as AT&T, SAP NS2, and A+E Networks trust Fugue to protect their cloud environments. Fugue’s investors include New Enterprise Associates, Future Fund, and In-Q-Tel (IQT). Fugue is an AWS Advanced Technology Partner and Cloud Management Competency Partner and has twice been named a CyberSecurity Breakthrough Award winner. To learn more, visit www.fugue.co.

Elissa Walters
Sonatype
480-818-0734
[email protected]

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Golar LNG Limited (“Golar” or the “Company”) (NASDAQ: GLNG). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether Golar and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On September 24, 2020, media outlets reported that Eduardo Navarro Antonello, Chief Executive Officer of Golar’s joint-venture subsidiary Hygo Energy Transition Ltd., had been implicated in a bribery network investigated in connection with the ongoing Brazilian criminal investigation Operation Car Wash. 

On this news, Golar’s stock price fell $3.28 per share, or approximately 32%, to close at $6.86 per share on September 24, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980

ORLANDO, Fla., Nov. 12, 2020 (GLOBE NEWSWIRE) — Sustainable Green Team, Ltd. (OTC: SGTM) (“SGTM” or the “Company”), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announces that its wholly owned subsidiary Mulch Manufacturing, Inc. has expanded its 2021 mulch contracts with Circle K convenient stores, a subsidiary of Alimentation Couche-Tard, Inc. (OTC: ANCUF) (“ANCUF”). The original contract, finalized in October, has been increased to add an additional region to the initial three, bringing the total to four. The mulch contract expansion was obtained shortly after the Company reported another successful quarter, generating approximately $24.5 million in revenue and $5.5 million in gross profit within the nine months ending Sept. 30, 2020.

About Sustainable Green Team, Ltd. (SGTM)

Sustainable Green Team, Ltd. (“SGTM”), through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The Company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The Company’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting tree debris through its tree services division and collection sites and then, through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The Company plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and are positioned for rapid growth from the resulting synergistic opportunities identified. The Company’s customers include governmental, residential and commercial clients.

SGTM currently has two wholly owned subsidiaries to efficiently assess areas, recover, manufacture and distribute:

National Storm Recovery, LLC

National Storm Recovery, LLC (“NSR”) is composed of a team that has expertise in dangerous tree removal, debris hauling and debris management. The Company’s management team assesses storms by deploying its mobile command center to designated sites and then strategizing with its national partners, which include government agencies, prime contractors and subcontractors.

Central Florida Arborcare (“CFA”), a DBA of NSR, has spent more than 40 years perfecting its technique for proper tree care, removal and services. From tree removal, stump grinding and tree care to grapple hauling and storm recovery, CFA ensures properties remain safe and businesses can continue as usual.

To learn more please visit: https://www.centralfloridaarborcare.com

Mulch Manufacturing, Inc.

Mulch Manufacturing, Inc. (“MMI”), being vertically integrated, receives a large volume of wood fiber recovered from Central Florida Arborcare to feed raw material needs. MMI has the product line and distribution system to address a substantial customer base, which can be expanded.

To learn more please visit: https://mulchmfg.com

For additional information regarding SGTM’s operations, expansion plans and production facilities, view the Company’s presentation.

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions, are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise. No information in this press release should be construed in any matter whatsoever as an indication of the future performance of the Company’s revenues, financial condition or stock price.

Company Contact:

Anthony Raynor
CEO & Director
407.886.8733 Office

Corporate Communications:

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

REDWOOD CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today introduced Biocare Telemed, a virtual clinic that provides user-friendly access for patients to receive outstanding medical care and remote patient cardiac monitoring from their physician of choice in the safety and comfort of their home.

“The arrival of COVID-19 has highlighted the importance of having remote care systems in place,” said Dr. Waqaas Al-Siddiq, founder & CEO, Biotricity Inc. “Biocare Telemed streamlines the process, allowing patients to skip the waiting room and receive excellent medical care when and where it’s needed without leaving the house.”

The Biocare Telemed platform is a complete solution for the clinic with the ability to book and manage appointments, connect diagnostic tools, and report, monitor and diagnose remotely using the Bioflux.

Traditional telemedicine provides consults for routine clinical needs as opposed to supporting the diagnostic and more complex needs of cardiac patients. With Biocare Telemed, clinicians can provide outstanding medical care to at-risk patients and those needing remote cardiac monitoring without leaving the safety of their home. The user-friendly platform helps ensure seamless integration into the clinics’ current workflow, saving time and reducing costs.

“Being able to provide my at-risk cardiac patients a HIPAA compliant telemedicine solution for virtual consults during COVID-19 has changed how I practice medicine,” said Dr. John Lassetter, President, Radial Heart First. “Biocare Telemed allows me to monitor and diagnose my patients from the safety of their homes. Telemedicine is here to stay as more and more patients are demanding virtual consults, and clinicians realize the benefits of it to their practices.”

Biotricity will initially offer the Biocare Telemed platform via limited release to selected physicians, followed by a broad rollout in Q4 2020.

For more information, visit www.biotricity.com.

About Biotricity, Inc.

Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity’s unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com.

MEDIA CONTACT
:

Donna Loughlin Michaels
LMGPR
408.393.5575
[email protected]

Important Cautions Regarding Forward-Looking
Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words “may,” “should,” “would,” “will,” “could,” “scheduled,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “seek,” “project,” or “goal” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements may include, without limitation, statements regarding (i) the plans, objectives and goals of management for future operations, including plans, objectives or goals relating to the design, development and commercialization of Bioflux or any of the Company’s other proposed products or services, (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items, (iii) the Company’s future financial performance, (iv) the regulatory regime in which the Company operates or intends to operate and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company’s current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company’s inability to obtain additional financing, the significant length of time and resources associated with the development of its products and related insufficient cash flows and resulting illiquidity, the Company’s inability to expand the Company’s business, significant government regulation of medical devices and the healthcare industry, lack of product diversification, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. These and other factors are identified and described in more detail in the Company’s filings with the SEC. There cannot be any assurance that the Company will ever become profitable. During the three months ended June 30, 2020 the Company incurred a net loss attributable to common stockholders of $3.4 million. The Company assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

BASKING RIDGE, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Dan Goldberger, Chief Executive Officer, and Brian Posner, Chief Financial Officer, will participate in two upcoming investor conferences:

Sidoti Virtual Microcap Conference 2020

Format: corporate presentation followed by 1×1 virtual investor meetings
Date: Thursday, November 19
Time: 10:45am – 11:45am ET

Investors can register for the webcast HERE.

Canaccord Genuity Virtual MedTech & Diagnostics Forum

Format: 1×1 virtual investor meetings
Date: Thursday, November 19

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:

Hans Vitzthum
LifeSci Advisors
617-430-7578
[email protected]

or

Media Contact:

Jackie Dorsky
electroCore
973-290-0097
[email protected]

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (“HC2” or the “Company”) (NYSE:HCHC), a diversified holding company, announced today that leading independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass Lewis have recommended, in connection with the Company’s current $65 million rights offering (the “Rights Offering”), that HC2 stockholders vote “FOR” both Proposals 1 and 2 at the Company’s Special Meeting of Stockholders to be held on November 20, 2020.

• Proposal 1 – to increase the number of authorized shares of common stock from 80 million to 160 million (the “Authorized Shares Proposal”).
• Proposal 2 – to approve the conversion of up to 35,000 shares of Series B preferred stock into common stock in connection with the Rights Offering.

Consummation of the Rights Offering is conditioned upon stockholder approval of the Authorized Shares Proposal. The Company believes that approval of both proposals will help ensure the successful completion of the Rights Offering, which will strengthen the Company’s balance sheet in advance of a potential refinancing of certain of its indebtedness.

HC2 expects to use the proceeds from the Rights Offering for general corporate purposes, including debt service and for working capital.

The Rights Offering will expire at 5:00 p.m., New York City time, on November 20, 2020, unless extended by the Company. The Company may extend the expiration date if stockholder approval of the Authorized Shares Proposal is not obtained on or prior to the previously scheduled expiration date. The Company reserves the right to amend or terminate the rights offering at any time prior to its expiration date.

A copy of the prospectus and prospectus supplement for the rights offering is available to stockholders on the Company’s website and at the website maintained by the U.S. Securities and Exchange Commission (the “SEC”) at www.sec.gov. Holders of shares of common stock in “street name” through a brokerage account, bank or other nominee will not receive physical rights certificates and must instruct their broker, bank or nominee whether to exercise subscription rights on their behalf. For any questions or further information about the rights offering, please call Okapi Partners LLC, the information agent for the Rights Offering, at (855) 208-8902 (toll-free).

Neither the Company nor its Board of Directors has, or will, make any recommendation to stockholders regarding the exercise or sale of rights in the Rights Offering. Stockholders should make an independent investment decision about whether or not to exercise or sell their rights based on their own assessment of the Company’s business and the Rights Offering.

The
R
ights
O
ffering
is being made
pursuant to HC2’s effective shelf registration statement on Form S-3, filed with the SEC on September 9, 2020, and a prospectus supplement containing the detailed terms of the
R
ights
O
ffering
filed with the SEC on October 7, 2020. The information in this press release is not complete and is subject to change. This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities, nor shall there be any offer, solicitation or sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful under the securities laws of such state or jurisdiction. The
R
ights
Offering
is being
made only by means of a prospectus and a related prospectus supplement, copies of which
have been
distributed to all eligible stockholders and may also be obtained free of charge at the website maintained by the SEC at www.sec.gov or by contacting the information agent for the rights offering.

About HC2

HC2 Holdings, Inc. is a publicly traded (NYSE:HCHC) diversified holding company, which seeks opportunities to acquire and grow businesses that can generate long-term sustainable free cash flow and attractive returns in order to maximize value for all stakeholders. HC2 has a diverse array of operating subsidiaries across multiple reportable segments, including Infrastructure, Clean Energy, Life Sciences, Spectrum, Insurance and Other. HC2’s largest operating subsidiary is DBM Global Inc., a family of companies providing fully integrated structural and steel construction services. Founded in 1994, HC2 is headquartered in New York, New York.

C
autionary Statement Regarding Forward-Looking Statemen
ts

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release contains, and certain oral statements made by our representatives from time to time may contain, forward-looking statements, including, among others, statements regarding the Rights Offering, including, among others, expected timing, the use of proceeds from the Rights Offering, the size of the Rights Offering and other terms of the Rights Offering, all of which involve risks, assumptions and uncertainties, many of which are outside of the Company’s control, and are subject to change. The consummation of the Rights Offering is also subject to certain conditions, including stockholder approval of the Authorized Shares Proposal and market conditions. Accordingly, no assurance can be given that the Rights Offering will be consummated on the terms described above or at all. All forward-looking statements speak only as of the date made, and unless legally required, HC2 undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Investor Relations
[email protected]
(212) 235-2691